Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Running

AI-TreatCancer AI-guided personalized T cell receptor transgenic T cell therapy against cancer

Coordinator
Deutsches Krebsforschungszentrum Heidelberg, Germany
Runs
1 June 2026 to 30 November 2027
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101293142

What the project is doing

In the project's own words, from its summary on CORDIS.

Personalised T cell therapy has shown remarkable success in cancer therapy, however the antigens that T cells recognize to kill tumor cells are dependent on the individual tumor, T cell receptor (TCR) profile and antigen presentation machinery. AI-TreatCancer will leverage predicTCR, a proprietary AI-guided classifier that identifies tumor-killing TCRs from patient samples, decreasing the time to identify therapeutic TCRs from 3-4 months to under 2 weeks.

In the ERC Advanced Grant (ERC-2023-ADG #101141901 — Characterizing and harnessing tumor-reactive T cells in the brain

Topics

Who is involved

OrganisationCityCountryRole
Deutsches Krebsforschungszentrum HeidelbergHeidelbergGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI